Hemostemix

CompanyCanada

Hemostemix develops one asset, in phase 1 (VesCell in angina). Mostly cell therapy; based in Canada.

1
Asset
Furthest stage
Phase 1
0
Trials
0
Signals

Pipeline

1
  • VesCell

    Autologous angiogenic cells promote blood vessel formation to improve tissue perfusion.

    Phase 1, Cell therapy, angina, pain

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Similar companies6

Intelligence